EHR integration, secure messaging tops list of CIOs 2018 priorities

Hospital Chief Information Officers (CIOs) are setting their sights on technology investments and challenges for 2018, according to a survey by Spok.

The survey, which includes responses from 46 CHIME CIOs, provides insight into what hospital executives are focusing on in the New Year.

Findings include:

  • 40 percent of CIOs report deploying an enterprise analytics platform as the top priority for 2018.
  • 79 percent state secure messaging and communications among care teams are driving their mobile technology selection, followed by receiving alerts from clinical systems (60 percent) and critical test result alerts (60 percent).
  • 65 percent of hospitals are working to incorporate mobile elements into their strategy to support clinical workflows; 26 percent are not developing mobile care tam strategy.
  • 76 percent of hospitals report progress toward implementing secure texting within mobile strategy in the next three years, followed by 70 percent for medication administration and 71 percent for clinical documentation.
  • 50 percent of CIOs report their hospitals have a patient experience officer or equivalent.
  • 45 percent of hospitals are evolving patient portals to support population health initiatives.
  • 62 percent of CIOs reported physician adoption and buy-in as their top priority for the next 18 months, followed by optimizing EHR integration with other hospital systems at 38 percent.
  • 71 percent of CIOs base decisions for communication technologies on their ability to integrate with EHRs, followed by integration with other systems (69 percent) and ease of use for end users (62 percent).

“CIOs are making thoughtful decisions about their technology investments. The point of view behind the healthcare CIO’s desk is one of challenges and opportunities, considering future investments and measuring success,” stated the report.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.